Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation. - Wikidata - awgldk - TriplyDB

Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation.

Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation.

http://www.wikidata.org/entity/Q37168346

about

Reduction of Relapse after Unrelated Donor Stem Cell Transplantation by KIR-Based Graft Selection.Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.

P2860

Q39147196-500DE551-F895-4ACB-B51A-17523315FD27 Q40093716-4C550045-767C-412D-BCD3-5FA1E0A27DE4

P2860

Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation.

http://www.wikidata.org/entity/Q37168346

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Donor KIR B Genotype Improves ...... related Donor Transplantation.

@en

Donor KIR B Genotype Improves ...... related Donor Transplantation.

@nl

type

label

Donor KIR B Genotype Improves ...... related Donor Transplantation.

@en

Donor KIR B Genotype Improves ...... related Donor Transplantation.

@nl

prefLabel

Donor KIR B Genotype Improves ...... related Donor Transplantation.

@en

Donor KIR B Genotype Improves ...... related Donor Transplantation.

@nl

P1433

Q37168346-5BC362E3-CFA8-436A-B889-7D906E6ED3CE

P1476

Q37168346-FF406AE6-F6EE-4BCD-A48E-851DE1AEA2BE

P2093

Q37168346-008E94D9-62EC-4DE4-ABB2-67FDB28D846F

Q37168346-1E3E7C07-F699-4143-89E5-33329E2F0252

Q37168346-2A3F40BF-2C9F-4901-A977-005E23099FFE

Q37168346-44FC10C9-8C1D-40DF-B693-6CE47CB89E45

Q37168346-502DDC32-D6EC-492F-97F5-98C2998A33E2

Q37168346-6F9BDFB1-05D3-4407-AF46-9608D391078C

Q37168346-B2BC0260-1CD1-4037-B8F4-940B3236C797

Q37168346-C06F1F64-CB47-4CFD-AE26-C6A1FF9265FA

Q37168346-E7E14866-03AC-4AF4-B64E-7B5EE6B2488B

Q37168346-FE3192C6-02BF-46A0-A772-DDAAD00E3301

P2860

Q37168346-0FF7700E-D861-489E-A6A8-7F60C7842D55

Q37168346-15B28535-5D86-411F-B322-3A485492950A

Q37168346-243D51D2-5F37-4EB1-BEE3-E8E4ED4DD15B

Q37168346-46869B39-B838-41F3-B64F-C9053C62A892

Q37168346-46EBC1E7-6F94-4589-8ACC-D16BC4AFDDC8

Q37168346-4F2033E5-87D6-4A8A-95BE-494D3FC9C8CE

Q37168346-7216E8BB-0B35-4AE6-98B6-2FD4114089FB

Q37168346-72BBE347-0F8A-4B3A-A132-2D4B98C2CD9B

Q37168346-74B346D5-DB05-42EB-A585-74E345359F9E

Q37168346-88224635-7891-43FE-9FFB-B909C3B3BADE

P304

Q37168346-7D2882DA-5420-47E9-9FA2-959F1178EBDE

P31

Q37168346-DD2D0F4C-C406-44D0-9FCE-747F0130E85E

P356

Q37168346-32A7DDD1-A919-40CF-B153-0048FD1D2F66

P433

Q37168346-4637F4BD-F11D-45C8-BE04-3B992CF7DEE5

P478

Q37168346-731BA247-6059-4377-8E10-6D69F7C3789D

P50

Q37168346-6B9F2269-3CE1-43E1-9282-79E12CA0E176

P577

Q37168346-2FF8F2D2-8D8D-4502-A41B-8CDC72E0EE98

P698

Q37168346-73998778-4BB1-4AFF-BC2A-2F861DD08E55

P932

Q37168346-425D1DF1-5DF6-44E4-8A14-EA00BC64A797

P356

J.BBMT.2016.05.016

P1433

Biology of Blood and Marrow Transplantation

P1476

Donor KIR B Genotype Improves ...... related Donor Transplantation.

@en

P2093

Daniel J Weisdorf

http://www.w3.org/2001/XMLSchema#string

Elizabeth Trachtenberg

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Miller

http://www.w3.org/2001/XMLSchema#string

Lisbeth A Guethlein

http://www.w3.org/2001/XMLSchema#string

Martha Ladner

http://www.w3.org/2001/XMLSchema#string

Michael D Haagenson

http://www.w3.org/2001/XMLSchema#string

Peter Parham

http://www.w3.org/2001/XMLSchema#string

Sarah A Cooley

http://www.w3.org/2001/XMLSchema#string

Stephen R Spellman

http://www.w3.org/2001/XMLSchema#string

Tao Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Up on the tightrope: natural killer cell activation and inhibition

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles.

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.

Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL.

Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.

Relapse of lymphoma after allogeneic hematopoietic cell transplantation: management strategies and outcome.

P304

1602-1607

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2016.05.016

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Steven G. E. Marsh

P577

2016-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27220262

http://www.w3.org/2001/XMLSchema#string

P932

4981536

http://www.w3.org/2001/XMLSchema#string